Authors: DUNNER D KUMAR R

Citation: D. Dunner et R. Kumar, PAROXETINE - A REVIEW OF CLINICAL-EXPERIENCE, Pharmacopsychiatry, 31(3), 1998, pp. 89-101

Authors: FAVA M DUNNER D GREIST J HORNIGROHAN M PRESKORN S TRIVEDI M ZAJECKA J COHEN M WINGARD P

Citation: M. Fava et al., AN OPEN-LABEL STUDY OF MIRTAZAPINE IN DEPRESSED-PATIENTS WHO FAILED TREATMENT WITH AN SSRI, Biological psychiatry, 41, 1997, pp. 330-330

Authors: SHRIVASTAVA RK COHN C CROWDER J DAVIDSON J DUNNER D FEIGHNER J KIEV A PATRICK R

Citation: Rk. Shrivastava et al., LONG-TERM SAFETY AND CLINICAL ACCEPTABILITY OF VENLAFAXINE AND IMIPRAMINE IN OUTPATIENTS WITH MAJOR DEPRESSION, Journal of clinical psychopharmacology, 14(5), 1994, pp. 322-329

Authors: HEILIGENSTEIN JH FARIES DE RUSH AJ ANDERSEN JS PANDE AC ROFFWARG HP DUNNER D GILLIN JC JAMES SP LAHMEYER H ZAJECKA J TOLLEFSON GD GARDNER DM

Citation: Jh. Heiligenstein et al., LATENCY TO RAPID EYE-MOVEMENT SLEEP AS A PREDICTOR OF TREATMENT RESPONSE TO FLUOXETINE AND PLACEBO IN NONPSYCHOTIC DEPRESSED OUTPATIENTS, Psychiatry research, 52(3), 1994, pp. 327-339

Authors: WINGERSON D SULLIVAN M DAGER S FLICK S DUNNER D ROYBYRNE P

Citation: D. Wingerson et al., PERSONALITY-TRAITS AND EARLY DISCONTINUATION FROM CLINICAL-TRIALS IN ANXIOUS PATIENTS, Journal of clinical psychopharmacology, 13(3), 1993, pp. 194-197

Authors: DUNNER D FEIGHNER J ROSENBAUM J WELLS B

Citation: D. Dunner et al., MANAGING DEPRESSION - A RATIONAL, COST-EFFECTIVE APPROACH, Hospital formulary, 28, 1993, pp. 14-30